Rubicon Organics Stock Today
| ROMJ Stock | CAD 0.34 0.04 13.33% |
Performance0 of 100
| Odds Of DistressLess than 20
|
Rubicon Organics is selling for under 0.34 as of the 25th of November 2024; that is 13.33 percent increase since the beginning of the trading day. The stock's lowest day price was 0.3. Rubicon Organics has about a 20 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Rubicon Organics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 6th of December 2022 and ending today, the 25th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Rubicon Organics Inc. produces and sells organic cannabis in Canada. Rubicon Organics Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada. RUBICON ORGANICS operates under Drug ManufacturersSpecialty Generic classification in Exotistan and is traded on Commodity Exchange.. The company has 56.21 M outstanding shares of which 9 shares are at this time shorted by private and institutional investors with about 0.0 days to cover all short positions. More on Rubicon Organics
Moving against Rubicon Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Rubicon Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Rubicon Organics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Rubicon Organics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | Natural Foods (View all Themes) | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Natural Foods, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | ||||
Rubicon Organics' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Rubicon Organics' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsRubicon Organics can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Rubicon Organics' financial leverage. It provides some insight into what part of Rubicon Organics' total assets is financed by creditors.
| |||||
Rubicon Organics (ROMJ) is traded on TSX Venture Exchange in Canada and employs 180 people. Rubicon Organics is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 19.11 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Rubicon Organics's market, we take the total number of its shares issued and multiply it by Rubicon Organics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Rubicon Organics operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 56.21 M outstanding shares of which 9 shares are at this time shorted by private and institutional investors with about 0.0 days to cover all short positions.
Rubicon Organics has accumulated about 4.22 M in cash with 6.79 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08.
Check Rubicon Organics Probability Of Bankruptcy
Ownership AllocationRubicon Organics owns a total of 56.21 Million outstanding shares. Rubicon Organics has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Rubicon Ownership Details
Rubicon Organics Risk Profiles
Although Rubicon Organics' alpha and beta are two of the key measurements used to evaluate Rubicon Organics' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.51 | |||
| Standard Deviation | 5.26 | |||
| Variance | 27.64 | |||
| Risk Adjusted Performance | (0.04) |
Rubicon Stock Against Markets
| ROMJ | 13.33 |
| Compare Correlations |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Rubicon Organics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Share Portfolio Now
Share PortfolioTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Rubicon Organics Corporate Management
Elected by the shareholders, the Rubicon Organics' board of directors comprises two types of representatives: Rubicon Organics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Rubicon. The board's role is to monitor Rubicon Organics' management team and ensure that shareholders' interests are well served. Rubicon Organics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Rubicon Organics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mathieu Aubin | Vice Business | Profile | |
| Monika Mascitti | Vice People | Profile | |
| Jesse MA | CEO CoFounder | Profile | |
| Benoit Pinsonneault | VP Sales | Profile | |
| Peter Dierx | VP Operations | Profile |
Additional Tools for Rubicon Stock Analysis
When running Rubicon Organics' price analysis, check to measure Rubicon Organics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rubicon Organics is operating at the current time. Most of Rubicon Organics' value examination focuses on studying past and present price action to predict the probability of Rubicon Organics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rubicon Organics' price. Additionally, you may evaluate how the addition of Rubicon Organics to your portfolios can decrease your overall portfolio volatility.